Batur Y - Search Results

1

Nitroimidazole-induced chronic hepatitis.

Ersoz G, Karasu Z, Akarca US, Gunsar F, Yuce G, Batur Y. Ersoz G, et al. Among authors: batur y. Eur J Gastroenterol Hepatol. 2001 Aug;13(8):963-6. doi: 10.1097/00042737-200108000-00015. Eur J Gastroenterol Hepatol. 2001. PMID: 11507363

2

Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y. Günsar F, et al. Among authors: batur y. Hepatogastroenterology. 2002 Sep-Oct;49(47):1195-200. Hepatogastroenterology. 2002. PMID: 12239904

3

Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.

Akarca US, Ersoz G, Gunsar F, Karasu Z, Saritas E, Yuce G, Batur Y. Akarca US, et al. Among authors: batur y. Antivir Ther. 2004 Jun;9(3):325-34. Antivir Ther. 2004. PMID: 15259895 Clinical Trial.

4

Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.

Gunsar F, Akarca US, Ersoz G, Kobak AC, Karasu Z, Yuce G, Ilter T, Batur Y. Gunsar F, et al. Among authors: batur y. Antivir Ther. 2005;10(6):721-6. Antivir Ther. 2005. PMID: 16218171 Clinical Trial.

5

Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome.

Colak Y, Karasu Z, Oruc N, Can C, Balým Z, Akarca U, Gunsar F, Ersoz G, Tokat Y, Batur Y. Colak Y, et al. Among authors: batur y. Eur J Gastroenterol Hepatol. 2006 Aug;18(8):917-20. doi: 10.1097/00042737-200608000-00019. Eur J Gastroenterol Hepatol. 2006. PMID: 16825912

6

Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C.

Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca US. Karasu Z, et al. Among authors: batur y. Dig Dis Sci. 2007 Jun;52(6):1535-9. doi: 10.1007/s10620-006-9144-y. Epub 2007 Apr 27. Dig Dis Sci. 2007. PMID: 17464564

7

Severe toxic hepatitis associated with amoxycillin and clavulanic acid.

Ersoz G, Karasu Z, Yildiz C, Akarca US, Yuce G, Batur Y. Ersoz G, et al. Among authors: batur y. J Clin Pharm Ther. 2001 Jun;26(3):225-9. doi: 10.1046/j.1365-2710.2001.00341.x. J Clin Pharm Ther. 2001. PMID: 11422607

8

Leukotriene receptor antagonism in experimental acute pancreatitis in rats.

Oruc N, Yukselen V, Ozutemiz AO, Yuce G, Celik HA, Musoglu A, Batur Y. Oruc N, et al. Among authors: batur y. Eur J Gastroenterol Hepatol. 2004 Apr;16(4):383-8. doi: 10.1097/00042737-200404000-00003. Eur J Gastroenterol Hepatol. 2004. PMID: 15028970

9

Interferon re-treatment for resistance to lamivudine plus interferon treatment.

Ersöz G, Akarca US, Günşar F, Karasu Z, Batur Y. Ersöz G, et al. Among authors: batur y. Turk J Gastroenterol. 2003 Dec;14(4):223-7. Turk J Gastroenterol. 2003. PMID: 15048595 Free article. Clinical Trial.

10

Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.

Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y. Karasu Z, et al. Among authors: batur y. Antivir Ther. 2004 Dec;9(6):921-7. Antivir Ther. 2004. PMID: 15651751 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters